Galapagos NV
GLPG
#5079
Rank
S$2.40 B
Marketcap
S$35.81
Share price
0.00%
Change (1 day)
-1.55%
Change (1 year)

EPS for Galapagos NV (GLPG)

EPS in 2026 (TTM): S-$0.56

According to Galapagos NV's latest financial reports the company's current EPS (TTM) is S-$0.53. In 2025 the company made an earnings per share (EPS) of S$7.39 an increase over its 2024 EPS that were of S$1.50.

EPS history for Galapagos NV from 2004 to 2026

Annual EPS

Year EPS Change
2026 (TTM)S-$0.56-107.59%
2025S$7.39390.86%
2024S$1.50-67.16%
2023S$4.58-199.64%
2022S-$4.6099.03%
2021S-$2.31-68.98%
2020S-$7.45-298.06%
2019S$3.76-554.64%
2018S-$0.83-77.18%
2017S-$3.63-326.21%
2016S$1.60-134.19%
2015S-$4.69-371.34%
2014S$1.73-445.98%
2013S-$0.5032.88%
2012S-$0.38-82.07%
2011S-$2.10-817.9%
2010S$0.2912.73%
2009S$0.26-120.79%
2008S-$1.25-37.67%
2007S-$2.0039.64%
2006S-$1.4328.17%
2005S-$1.126.25%
2004S-$1.05

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
S$11.28-2,244.61%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
S$4.66-985.84%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
S$2.66-604.81%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
S$3.31-728.35%๐Ÿ‡ซ๐Ÿ‡ท France
Merck
MRK
S$4.59-973.26%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
S$8.97-1,806.09%๐Ÿ‡ฌ๐Ÿ‡ง UK
GSK plc
GSK
S$5.02-1,054.01%๐Ÿ‡ฌ๐Ÿ‡ง UK
Fortress Biotech
FBIO
S-$0.79 49.74%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
S$1.77-436.31%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel